Invitation: From August 24 t€₽o August 25, 2023, Haibu Pδγharmaceutical invites you ¶£δ•to gather in Jinan, Shand∏Ωong for the National Phar€₽maceutical CXO + MAH Cooperatio♦ ↑∞n and Docking Conference.
Classification:
Recent Events
Release time:
2023-09-18

Beijing Haibu Pharmaceutical Technγ'≥"ology Co., Ltd. (referred to as "Ha∏↑γ ibu Pharmaceutical") wa&$<s established in 2005 aδ×nd is a high-tech enterprise with "c↑≈±'hemical drug research and develop©♣ment" as its core cap¥>ability. It has a resear®"πch and development center in γεBeijing, a pilot verification centerπ✘→ for raw materials and f →₩ormulations, and a GMP industri♠©∏®al production base, mainly engaged in Cπ≈RO services for raw materials and φ$ formulations, MAH joint licensing,★® related applications for λraw materials, and commercial supply o "♠f pharmaceutical intermediate÷←λ§s.
It has rich experience in th♣φ₩e research and production ' transfer, registration app∑Ω÷αlication, etc., of var§σious dosage forms such as chemical↔≠ raw materials, oral solids, liquidΩ< preparations, sterile injections, and↑" external preparations.£₹§ The R&D products cover♣Ω§∏ multiple therapeutic areas inc→ ≠luding anti-tumor, anti-depression,"÷≤ anti-epilepsy, anti-anxie®✔≠ty, cardiovascular an≠ §d cerebrovascular di✘₽₹©seases, digestive system d>$♣isorders, respiratory system is©σ¶πsues, etc.
Haibu Pharmaceutical has™• been awarded the title of "Top★ ≤↔ 20 Chinese Pharmaceutical÷↑♦ R&D Companies" for severalδ σ₹ consecutive years and has be& £en recognized as a "Specialized and Innλ↓✘ovative" enterprise in Beijing,♣φ a "National High-tech Enterprise", a¥←≠ "Beijing Science and Technology ReseγλΩarch Development Instituti§ "on", and a "Beijing Yizhuang Enterprise♦λ→® Innovation Center", among others.



